The Drug Schedules and What Each One Restricts
Placement in a schedule is not a label but a set of operating rules. It decides whether a substance may be prescribed at all, whether the prescription may be refilled, how the stock is stored and which records must be kept apart from everything else.
The rule in short
Congress set five schedules and gave the Attorney General authority to add, remove or move substances after a scientific and medical evaluation. Each placement rests on findings about abuse potential, accepted medical use and the dependence a substance produces. The schedule then determines the ordering, prescribing, refill, storage and recordkeeping rules that apply, and a change in schedule changes all of them at once.
The five schedules are the spine of federal drug regulation. Every downstream rule — who may prescribe, whether a prescription may be refilled, how stock is ordered, where it is kept and how long the records live — reads off the schedule number. Understanding the criteria matters less for its own sake than for predicting what changes when a substance moves.
The three findings behind each placement
The statute describes each schedule through three findings: the substance's potential for abuse, whether it has a currently accepted medical use in treatment in the United States, and the degree of physical or psychological dependence that abuse may lead to.
Schedule I is reserved for substances with a high potential for abuse, no currently accepted medical use in treatment, and a lack of accepted safety for use under medical supervision. Schedule II shares the high abuse potential but has an accepted medical use, with abuse liable to lead to severe dependence. Schedule III sits below both, with abuse potentially leading to moderate or low physical dependence or high psychological dependence. Schedule IV has a low potential for abuse relative to Schedule III, and Schedule V lower still.
These are relative findings, not absolute measurements. A substance is placed by comparison with those already scheduled, which is why the eight factors the agency must consider include the state of current scientific knowledge, the scope and significance of diversion, and the risk to public health rather than pharmacology alone.
What the schedule actually changes
Schedule I substances may not be dispensed on a prescription at all. Handling them requires a research or analytical registration and, for Schedule I research, an approved protocol. There is no lawful retail route.
Schedule II is the operational dividing line for a pharmacy. Dispensing requires a written prescription signed by the practitioner, or a compliant electronic prescription. Refilling is prohibited outright. A prescriber may issue multiple sequential prescriptions covering up to a ninety-day supply, with written instructions on each after the first showing the earliest date a pharmacy may fill it, but each of those is a separate prescription rather than a refill. Emergency oral authorization is permitted for the quantity needed during the emergency period, with a written prescription to follow within seven days.
Schedules III and IV allow oral and facsimile prescriptions and permit up to five refills within six months of issue. Schedule V includes products that may in some circumstances be dispensed without a prescription by a pharmacist, subject to strict conditions on quantity, purchaser identification and a bound record.
| Schedule | Prescription permitted | Refills | Ordering | Inventory count |
|---|---|---|---|---|
| I | No; research or analytical use only | Not applicable | Order form required | Exact count |
| II | Written or electronic; oral only in an emergency | None | Order form required | Exact count |
| III | Written, oral, facsimile or electronic | Up to five within six months | Invoice | Estimated count permitted for smaller containers |
| IV | Written, oral, facsimile or electronic | Up to five within six months | Invoice | Estimated count permitted for smaller containers |
| V | Prescription, or dispensing without one in limited cases | As authorized by the prescriber | Invoice | Estimated count permitted for smaller containers |
How a substance moves between schedules
Rescheduling is rulemaking, not an announcement. A proceeding may begin on the agency's own motion, on the request of the Department of Health and Human Services, or on the petition of an interested party, including a manufacturer or a medical association.
Before control is imposed or changed, the agency requests a scientific and medical evaluation and a recommendation from the Department of Health and Human Services. The recommendations on scientific and medical matters are binding to the extent that the agency may not schedule a substance if that department recommends against control. The agency then weighs the eight statutory factors, publishes a proposed rule, takes comment, and issues a final order. Interested parties may request a hearing on the record before the order becomes final.
When a rule adds a previously uncontrolled substance to any schedule, every registrant holding that substance must take an inventory of all stocks on hand on the effective date of the rule. It is an easy step to miss, because the substance was not on the controlled list the day before and nothing about the physical stock has changed. From that date the substance is included in every subsequent biennial inventory.
The day a change takes effect
A schedule change is not gradual. On the effective date, the ordering rules, the prescription form requirements, the refill limits, the storage standard and the record separation obligations all switch together for that substance.
A move into Schedule II means outstanding refills are no longer valid, that the substance must be ordered on the closed system used for Schedules I and II, and that records for it must be maintained separately from all other records. A move out of Schedule II in the other direction relaxes those constraints but does not retroactively cure anything done under the old rule. Registrants that dispense a rescheduled substance typically face a short window in which existing prescriptions must be reassessed and the physical stock relocated, since the storage and inventory requirements differ by schedule.
Prescribers face a parallel problem. A prescription written before the change but presented after it is judged by the rules in force when it is filled, which means the pharmacy — not the prescriber — is the party that must recognize the mismatch. That is the practical face of the pharmacist's duty to refuse a prescription that cannot lawfully be filled as written.
Exempt, excluded and listed chemical products
Not everything containing a scheduled substance is controlled at the point of sale. The rules recognize excluded non-narcotic products lawfully sold over the counter, exempt anabolic steroid products, and exempt chemical preparations used in laboratories where the substance is present in a form that cannot readily be recovered.
Separately, some non-controlled chemicals are regulated as listed chemicals because they can be used to manufacture controlled substances. Those carry their own recordkeeping, reporting and threshold rules and are not schedules at all, though registrants often encounter them in the same regulatory chapter and mistake one regime for the other.
A product's status is determined by the listing, including any concentration limits stated in it, and by any published exemption. Where a registrant is uncertain, the conservative course is to treat the product as controlled at the higher level until the listing is checked, because the reporting duty for a theft or significant loss attaches to controlled stock whether or not the registrant realized it was controlled.
Points to carry away
- Schedule I substances have no accepted medical use in treatment and may not be prescribed, only handled under a research registration.
- Schedule II substances may be dispensed only on a written or electronic prescription and may not be refilled at all.
- Schedules III and IV allow up to five refills within six months of the date the prescription was issued.
- Scheduling decisions follow a formal process with a scientific and medical evaluation from the Department of Health and Human Services.
- A rescheduling order changes ordering, refill, storage and record obligations simultaneously, and triggers a fresh inventory of the substance.
Questions readers ask
Why do some products containing a controlled substance sit in a lower schedule?
Because the schedules list substances at stated concentrations and in stated combinations, not chemicals in the abstract. A narcotic combined with a specified quantity of a non-narcotic ingredient, in amounts that confer a valuable medicinal quality other than the narcotic effect, can appear in a lower schedule than the pure substance. Schedule V is largely made up of preparations of that kind, described by milligrams of narcotic per unit or per hundred milliliters. The listing controls, so the product must be matched against the entry rather than against the active ingredient alone.
Does a state schedule have to match the federal one?
No. States run their own controlled substances acts and may place a substance in a stricter schedule than the federal one, may schedule something federal law does not, and may follow federal action automatically or only after their own rulemaking. A registrant must satisfy both. Where the schedules diverge, the more restrictive rule governs in practice, because complying with the looser one does not excuse a violation of the stricter. State law also frequently adds prescribing and quantity limits that have no federal counterpart.
What is a temporary scheduling order?
It is a mechanism for placing a substance in Schedule I quickly when that is necessary to avoid an imminent hazard to public safety, without waiting for the full evaluation the ordinary process requires. The order is time-limited and can be extended while the permanent proceeding runs. Substances placed this way carry the full weight of Schedule I while the order is in effect, which means registrants may not dispense them and any stock on hand must be handled under research or disposal authority rather than sold through.
Sources
- 21 U.S.C. § 812 — Schedules of controlled substancesSets the five schedules and the findings required for placement in each.
- 21 U.S.C. § 811 — Authority and criteria for classificationGoverns adding, removing and transferring substances, including the eight-factor analysis.
- 21 U.S.C. § 829 — PrescriptionsStates the prescription and refill restrictions that follow from schedule placement.
- 21 CFR § 1308.12 — Schedule IIThe current Schedule II listing, including concentration-specific entries.
- 21 CFR § 1308.13 — Schedule IIIThe current Schedule III listing and the combination products placed there.
- DEA Diversion Control Division — Controlled Substance SchedulesThe agency's consolidated listing and its record of scheduling actions.
Metro Law Advisors is a publication, not a law firm. This article states general rules and cites its sources; it is not advice about any particular case, and the law differs by state and changes over time.
More in Pharmacy & Controlled Substances
Registering to Handle Controlled Substances
Federal law requires a separate registration for each principal place of business where controlled substances are manufactured, distributed or dispensed, and a separate registration for each independent group of activities. A practitioner registration depends on state authority to dispense: when the state license ends, the federal authority it rests on ends with it. Registrations expire on assigned cycles and must be modified when the address or the schedules handled change.
Refills, Transfers and Partial Fills by Schedule
Schedule II prescriptions may not be refilled and their partial fills run on tight deadlines measured from the prescription or the first fill. Schedules III and IV permit up to five refills within six months of issue, and refill information may be transferred between pharmacies once unless they share a real-time database. Every partial fill and refill generates a record entry, and the total dispensed can never exceed the quantity prescribed.
Inspections, Show Cause Hearings and Surrendering a Registration
An administrative inspection begins with a notice of inspection and a decision whether to consent; without consent a warrant is generally required, subject to stated exceptions. An order to show cause opens a case to deny, suspend or revoke a registration and must allow at least thirty days before appearance, with a hearing request and answer due in that period. Where imminent danger is found, the registration may be suspended immediately.